Filing Details

Accession Number:
0001209191-16-121073
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-17 20:36:28
Reporting Period:
2016-05-13
Filing Date:
2016-05-17
Accepted Time:
2016-05-17 20:36:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649989 Oncobiologics Inc. ONS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527197 Kenneth Bahrt C/O Oncobiologics, Inc.
7 Clarke Drive
Cranbury NJ 08521
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-13 2,000 $0.00 2,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Warrants (right to buy) Acquisiton 2016-05-13 1,000 $0.00 1,000 $6.60
Common Stock Series B Warrants (right to buy) Acquisiton 2016-05-13 1,000 $0.00 1,000 $8.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 2017-02-18 No 4 P Direct
1,000 2018-05-18 No 4 P Direct
Footnotes
  1. The reported securities are included within 2,000 Units purchased by the reporting person for $6.00 per Unit. Each Unit consists of one share of common stock, one half of a Series A warrant to purchase one share of common stock and one half of a Series B Warrant to purchase one share of common stock
  2. The Series A Warrants and Series B Warrants will be exercisable 30 days after 5/12/16 or on such date the underwriters separate the units, whichever date is earlier.